NO975220L - Ny fremgangsmåte for fremstilling av ropivacainhydrokloridmonohydrat - Google Patents

Ny fremgangsmåte for fremstilling av ropivacainhydrokloridmonohydrat

Info

Publication number
NO975220L
NO975220L NO975220A NO975220A NO975220L NO 975220 L NO975220 L NO 975220L NO 975220 A NO975220 A NO 975220A NO 975220 A NO975220 A NO 975220A NO 975220 L NO975220 L NO 975220L
Authority
NO
Norway
Prior art keywords
preparation
new process
hydrochloride monohydrate
ropivacaine hydrochloride
ropivacaine
Prior art date
Application number
NO975220A
Other languages
English (en)
Other versions
NO309035B1 (no
NO975220D0 (no
Inventor
Peter Jaksch
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO975220L publication Critical patent/NO975220L/no
Publication of NO975220D0 publication Critical patent/NO975220D0/no
Publication of NO309035B1 publication Critical patent/NO309035B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
NO975220A 1995-05-16 1997-11-13 Ny fremgangsmÕte for fremstilling av ropivacainhydrokloridmonohydrat NO309035B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501808A SE9501808D0 (sv) 1995-05-16 1995-05-16 New process
PCT/SE1996/000563 WO1996036606A1 (en) 1995-05-16 1996-04-30 New process for the preparation of ropivacaine hydrochloride monohydrate

Publications (3)

Publication Number Publication Date
NO975220L true NO975220L (no) 1997-11-13
NO975220D0 NO975220D0 (no) 1997-11-13
NO309035B1 NO309035B1 (no) 2000-12-04

Family

ID=20398325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975220A NO309035B1 (no) 1995-05-16 1997-11-13 Ny fremgangsmÕte for fremstilling av ropivacainhydrokloridmonohydrat

Country Status (34)

Country Link
US (1) US5959112A (no)
EP (1) EP0828711B1 (no)
JP (1) JP3079112B2 (no)
KR (1) KR100425232B1 (no)
CN (1) CN1121388C (no)
AR (1) AR002737A1 (no)
AT (1) ATE207900T1 (no)
AU (1) AU696875B2 (no)
BR (1) BR9608820A (no)
CA (1) CA2219308C (no)
CZ (1) CZ290576B6 (no)
DE (1) DE69616543T2 (no)
DK (1) DK0828711T3 (no)
EE (1) EE03394B1 (no)
ES (1) ES2166888T3 (no)
HK (1) HK1009805A1 (no)
HU (1) HU221793B1 (no)
IL (1) IL118178A (no)
IN (1) IN185146B (no)
IS (1) IS1832B (no)
MY (1) MY115018A (no)
NO (1) NO309035B1 (no)
NZ (1) NZ308249A (no)
PL (1) PL184767B1 (no)
PT (1) PT828711E (no)
RU (1) RU2167153C2 (no)
SA (1) SA96160764B1 (no)
SE (1) SE9501808D0 (no)
SK (1) SK281812B6 (no)
TR (1) TR199701362T1 (no)
TW (1) TW340841B (no)
UA (1) UA46770C2 (no)
WO (1) WO1996036606A1 (no)
ZA (1) ZA963545B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2222614T3 (es) 1997-11-12 2005-02-01 Mitsubishi Chemical Corporation Derivados de purina y medicina que los contiene como ingrediente activo.
DE60006663T2 (de) 1999-05-11 2004-10-07 Mitsubishi Chem Corp Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung
AU1037701A (en) * 1999-10-20 2001-04-30 Smithkline Beecham Plc Process for the preparation of 4-(fluorophenyl)piperidine esters
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009044404A1 (en) * 2007-10-01 2009-04-09 Ramniwas Goel Process for the preparation of (s)-ropivacaine hydrochloride monohydrate
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
WO2014009964A1 (en) * 2012-07-11 2014-01-16 Neon Laboratories Limited Process for enantiomeric enrichment of 2 ', 6 ' - pipecoloxylidide
CN103086954A (zh) * 2013-02-04 2013-05-08 山东省医药工业研究所 一种制备罗哌卡因的方法
CN104003930B (zh) * 2014-06-13 2016-06-08 山东金诃药物研究开发有限公司 一种盐酸罗哌卡因的制备方法
CN113105386B (zh) * 2021-04-10 2022-11-25 河北一品制药股份有限公司 一种盐酸罗哌卡因一水合物工业化的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE341404B (no) * 1967-05-18 1971-12-27 Sterling Drug Inc
EP0151110B1 (en) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning

Also Published As

Publication number Publication date
SK151297A3 (en) 1998-05-06
ES2166888T3 (es) 2002-05-01
IL118178A0 (en) 1996-09-12
CN1189822A (zh) 1998-08-05
AU5783296A (en) 1996-11-29
IN185146B (no) 2000-11-25
DE69616543T2 (de) 2002-06-27
EP0828711B1 (en) 2001-10-31
NZ308249A (en) 1998-08-26
AR002737A1 (es) 1998-04-29
JP3079112B2 (ja) 2000-08-21
IS4607A (is) 1997-11-04
KR19990014827A (ko) 1999-02-25
HUP9900327A2 (hu) 1999-05-28
PT828711E (pt) 2002-04-29
NO309035B1 (no) 2000-12-04
CZ345297A3 (cs) 1998-03-18
KR100425232B1 (ko) 2004-05-20
CA2219308A1 (en) 1996-11-21
PL184767B1 (pl) 2002-12-31
PL323461A1 (en) 1998-03-30
MY115018A (en) 2003-03-31
DK0828711T3 (da) 2002-02-11
US5959112A (en) 1999-09-28
AU696875B2 (en) 1998-09-17
IS1832B (is) 2002-10-30
SA96160764B1 (ar) 2006-07-30
HU221793B1 (hu) 2003-01-28
IL118178A (en) 2003-07-31
CA2219308C (en) 2007-12-18
RU2167153C2 (ru) 2001-05-20
EE9700301A (et) 1998-06-15
ATE207900T1 (de) 2001-11-15
EP0828711A1 (en) 1998-03-18
EE03394B1 (et) 2001-04-16
BR9608820A (pt) 1999-06-15
TR199701362T1 (xx) 1998-05-21
HK1009805A1 (en) 1999-06-11
TW340841B (en) 1998-09-21
JPH11505242A (ja) 1999-05-18
SE9501808D0 (sv) 1995-05-16
SK281812B6 (sk) 2001-08-06
NO975220D0 (no) 1997-11-13
ZA963545B (en) 1996-11-18
CZ290576B6 (cs) 2002-08-14
WO1996036606A1 (en) 1996-11-21
DE69616543D1 (de) 2001-12-06
UA46770C2 (uk) 2002-06-17
CN1121388C (zh) 2003-09-17
HUP9900327A3 (en) 2001-05-28

Similar Documents

Publication Publication Date Title
NO970939D0 (no) Fremgangsmåte ved fremstilling av paroksetinhydrokloridanhydrat
NO964950D0 (no) Krystallinsk hydroklorid av (R)-(-)-2-æN-[4-1,1-dioksido-3-okso-2,3-dihydrobenzisotiazol-2-yl)-butylÅ-aminometylå-chroman
EE03351B1 (et) Meetod lerkanidipiinhüdrokloriidi valmistamiseks
NO20013569D0 (no) Fremgangsmåte ved fremstilling av L-fenylephrine-hydroklorid
NO975220L (no) Ny fremgangsmåte for fremstilling av ropivacainhydrokloridmonohydrat
NO982237D0 (no) Ny fremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
NO973835D0 (no) Fremgangsmåte for fremstilling av lorakarbefmonohydrat
FI963466A (fi) Menetelmä selluloosakarbamaatin valmistamiseksi
FI974002A (fi) Menetelmä ranitidiinihydrokloridi 1 muodon valmistamiseksi
NO962809D0 (no) Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin
SI0828711T1 (en) New process for the preparation of ropivacaine hydrochloride monohydrate
FI971964A (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
HRP960445B1 (en) New process for the preparation of ropivacaine hydrochloride monohydrate
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
HUP9600316A2 (en) Process for the preparation of n-(ortho-alkyl-phenyl)-imides
NO932528L (no) Fremgangsmåte for fremstilling av Form 1 renitidinhydroklorid
FI960790A0 (fi) Menetelmä fluoreenibisfenolin valmistamiseksi
ITMI950539A0 (it) Procedimento per la preparazione di diidropiridine

Legal Events

Date Code Title Description
MK1K Patent expired